
Mallinckrodt Pharmaceuticals plc is an Irish-American manufacturer of specialty pharmaceuticals, generic drugs and imaging agents. In 2017, it had 5,500 employees and sales of $3.2 billion, of which $2.9 billion was from the U.S. healthcare system. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Mallinckrodt (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
47%
Total
Publications
6.6K
Total Open
Publications
3.1K
Total
Citations
322K
Open Access
Percentage
47%
Total
Publications
6.6K
Total Open
Publications
3.1K
Total
Citations
322K
Breakdown
Publisher Open
12%
Both
20%
Other Platform Open
14%
Closed
54%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 39%
813
Hybrid 19%
392
No Guarantees 42%
888
Other Platform Open
Domain 74%
1.7K
Other Internet 23%
519
Institution 22%
501
Preprint 4%
99
Public 2%
38
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 1.7K |
DOI | Other Internet | 518 |
Washington University in St. Louis | Institution | 380 |
Europe PMC | Domain | 71 |
bioRxiv | Preprint | 49 |
Figshare | Public | 37 |
medRxiv | Preprint | 27 |
Royal Netherlands Academy of Arts and Sciences | Institution | 21 |
Office of Scientific and Technical Information | Institution | 21 |
University of Padua | Institution | 14 |